Since the publication of the 2019 European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) Guidelines for the management of dyslipidemia, various landmark clinical trials regarding therapies for dyslipidemia have been publ...

Follicular lymphoma (FL) is an indolent form of non-Hodgkin’s lymphoma (NHL) that originates from germinal centre B cells 1 and is the second most common NHL subtype worldwide. Although first-line treatment achieves a complete response (CR) an...

Hodgkin’s lymphoma (HL) is a rare monoclonal lymphoid neoplasm that consists of two subtypes: classical HL (cHL- 95% cases) and nodular lymphocyte predominant HL (NLP-HL) 1,2 . Notably, cHL has a bimodal age distribution that initially peaks a...

Chronic Hepatitis B (CHB) remains a substantial public health burden in Hong Kong, with recent data indicating approximately 5.6% of the local population living with the infection, affecting over 410,000 individuals 1 . While antiviral therapies hav...

CLL (chronic lymphocytic leukemia) and SLL (small lymphocytic lymphoma) are of the same disease. But, in CLL cancer cells are mostly found in the blood and bone marrow; while in SLL cancer cells are mostly found in the lymph nodes. CLL/SLL belongs t...

Statins are the front-line therapeutic agents for preventing cardiovascular diseases (CVD) and atherosclerotic disorders related to hypercholesterolemia by lowering low-density lipoprotein cholesterol (LDL-C) levels 1 . In addition to this primary i...

The disease burden of mental disorders has become increasingly relevant as this causes a high degree of individual and social suffering, whereas mood and anxiety disorders are commonly involved. Previous pooled analysis suggested that the lifetime p...

Hodgkin lymphoma (HL) is a rare B-cell lymphatic malignancy distinguished by its unique histological, immunophenotypic, and clinical characteristics 1,2 . According to the 2022 Hong Kong Cancer Registry data, HL accounts for ~3% of all haematologica...

Hyperphosphataemia is a hallmark of chronic kidney disease–mineral and bone disorder (CKD-MBD), contributing significantly to vascular calcification, cardiovascular morbidity, and mortality in dialysis patients 1-2 . Effective management of el...

Chronic hepatitis B (CHB) is one of the leading causes of hepatocellular carcinoma (HCC), cirrhotic complications and liver-related death worldwide. Therefore, controlling chronic hepatitis B virus (HBV) infection is crucial for reducing the risk of...

Multiple myeloma (MM) is one of the most common haematological malignancies with a global incidence ranging from 0.5 to 5 per 100,000 1 . It is characterised by the monoclonal proliferation of malignant plasma cells in the bone marrow, leading to da...

The elevation of low-density lipoprotein cholesterol (LDL-C) is a key aspect of dyslipidaemia and is associated with an increased cardiovascular risk, especially in atherosclerotic cardiovascular disease (ASCVD). While numerous studies advocate the ...